bioinformatics
John Steuart was a panelist at The Deal’s webcast audio seminar: Technology Transfer in the 21st Century, on May 12, 2011 (also participating as a panelist – Jeff Jensen, CEO, Fluxion Biosciences Inc. a Claremont Creek Ventures portfolio company) A recording of the seminar is now available to play online or download through 8/12/2011. Click […]
Read MoreMay 11, 2011 source: Wall Street Journal Health Blog Public Education and Gene Testing to Improve Medication Adherence There are tons of reasons why people don’t take the medications they’ve been prescribed, including side effects, cost and complicated drug regimens. A couple of different approaches to improving adherence are in the news today. The first […]
Read MoreApril 5, 2011 source: Gene Security Network press release Gene Security Network (GSN) welcomes the birth of the first baby to be born following the use of GSN’s novel Parental SupportTM technology for single gene preimplantation genetic diagnosis (PGD) and concurrent 24-chromosome screening. This test allows couples who are at risk to have children […]
Read MoreMarch 25, 2011 source: VentureWire by Timothy Hay AssureRx Health Inc. has raised an $11 million Series B round from Sequoia Capital and Claremont Creek Ventures for its testing system that helps psychiatric patients find the most compatible medications, according to an investor. “This could be one of the biggest diagnostic companies of the decade, […]
Read More
– Personalized Medicine Company to Expand Marketing and Product Development for Neuropsychiatric Pharmacogenetics – CINCINNATI, March 25, 2011 – AssureRx Health, Inc. today announced the closing of an $11 million Series B financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug and the right dose for individual neuropsychiatric […]
Read MoreMarch 1, 2011 source: Enhanced Online News (EON) – Three Arch Partners, Hambrecht & Quist lead financing, join board – Initial investor Claremont Creek Ventures also participates – Tibion Corporation, the privately held Silicon Valley firm transforming stroke rehabilitation with its robotic Bionic Leg, announced today the successful closure of a $10.175 million financing round, a new […]
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.